Organon (OGN) Dividends Paid - Common (2021 - 2026)
Organon (OGN) posted quarterly Dividends Paid - Common of $6.0 million for Q2 2026, down 40.0% year-over-year from $10.0 million in Q2 2025, and up 20.0% on a QoQ basis from $5.0 million in Q1 2026.
Organon (OGN) Dividends Paid - Common (2021 - 2026) Analysis & Trends
Organon has reported Dividends Paid - Common for 6 years, with the latest figure at $6.0 million in Q2 2026.
- Dividends Paid - Common for Q2 2026 came in at $6.0 million, down 40.0% year-over-year; the trailing twelve-month figure through Jun 2026 was $18.0 million (down 92.14% YoY), and the FY2025 annual result was $88.0 million, down 70.37% from the prior year.
- Dividends Paid - Common climbed to $6.0 million in Q2 2026, from $5.0 million in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $79.0 million in Q2 2024 and troughed at $3.0 million in Q3 2025.
- A 5-year average of $54.4 million and a median of $72.5 million in 2022 frame the typical range for Dividends Paid - Common.
- The widest annual swing landed in 2024, when Dividends Paid - Common increased 6.76%; it then sank 95.95% in 2025.
- A 5-year view of Dividends Paid - Common shows it stood at $73.0 million in 2022, then changed by 0.0% to $73.0 million in 2023, then grew by 1.37% to $74.0 million in 2024, then sank by 94.59% to $4.0 million in 2025, then jumped by 50.0% to $6.0 million in 2026.
- Per Business Quant data, the three most recent Dividends Paid - Common figures were $6.0 million in Q2 2026, $5.0 million in Q1 2026, and $4.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Organon | 3.61 Bn | 2.48 Bn | 847.00 Mn | 6.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Dec 31, 2025 | 4.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 71.00 Mn |
| Mar 31, 2025 | 71.00 Mn |
| Dec 31, 2024 | 74.00 Mn |
| Dec 31, 2024 | 74.00 Mn |
| Sep 30, 2024 | 74.00 Mn |
| Sep 30, 2024 | 74.00 Mn |
| Jun 30, 2024 | 79.00 Mn |
| Jun 30, 2024 | 79.00 Mn |
| Mar 31, 2024 | 70.00 Mn |
| Mar 31, 2024 | 70.00 Mn |